Compare TMHC & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMHC | NOVT |
|---|---|---|
| Founded | 1936 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 2012 | 1999 |
| Metric | TMHC | NOVT |
|---|---|---|
| Price | $58.02 | $116.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | $78.75 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 1.0M | 360.5K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.77 | 1.47 |
| Revenue | ★ $4,762,059,000.00 | $521,290,000.00 |
| Revenue This Year | N/A | $8.71 |
| Revenue Next Year | $8.86 | $6.47 |
| P/E Ratio | ★ $7.47 | $79.30 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $51.90 | $98.27 |
| 52 Week High | $72.27 | $149.95 |
| Indicator | TMHC | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 42.08 |
| Support Level | $57.19 | $111.58 |
| Resistance Level | $65.18 | $124.97 |
| Average True Range (ATR) | 1.57 | 5.19 |
| MACD | 0.06 | 0.42 |
| Stochastic Oscillator | 30.96 | 44.24 |
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.